Rivastigmine
Links shared publicly online about this topic
Psychiatry Medical News about Rivastigmine
mdlinx.com — “Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses” View full resource at mdlinx.com
Most Recently Shared on June 8, 2010 at 2:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses: Internation... http://bit.ly/9hPAKH #PSY
ingentaconnect Transdermal Rivastigmine: Management of Cutaneous Adverse Events ...
ingentaconnect.com — “ingentaconnect Transdermal Rivastigmine: Management of Cutaneous Adverse Events ...” View full resource at ingentaconnect.com
Most Recently Shared on June 28, 2011 at 3:25 pm By:
Transdermal Rivastigmine: Management of Cutaneous Adverse Events and Review of the Literature: (Source: CNS Drugs) http://bit.ly/mBghyz
Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine
guidance.nice.org.uk — “Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine” View full resource at guidance.nice.org.uk
Most Recently Shared on March 23, 2011 at 9:59 am By:
Alzheimer's drugs can now be prescribed on the NHS in mild disease, as new NICE guidance comes into force: http://guidance.nice.org.uk/TA217
Neurology Medical News about Alzheimer Disease Administration, Cutaneous Rivastigmine
mdlinx.com — “Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease” View full resource at mdlinx.com
Most Recently Shared on March 15, 2010 at 1:20 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#Neurology Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease: Internationa... http://bit.ly/baNNIl
IngentaConnect Rivastigmine: REM sleep behaviour disorder in an elderly patient:...
ingentaconnect.com — “IngentaConnect Rivastigmine: REM sleep behaviour disorder in an elderly patient:...” View full resource at ingentaconnect.com
Most Recently Shared on June 29, 2010 at 11:34 am By:
Rivastigmine: REM sleep behaviour disorder in an elderly patient: case report: (Source: Reactions) http://bit.ly/crCUv4
Sun Pharma introduces generic rivastigmine capsules in U.S. market
news-medical.net — “Sun Pharma announced launch of generic Exelon, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.” View full resource at news-medical.net
Most Recently Shared on July 2, 2010 at 6:23 am By:
Sun Pharma introduces generic rivastigmine capsules in U.S. market: Sun Pharma announced launch of generic Exelon,... http://bit.ly/8Xi8nH
Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia: An ADAS-Cog Factor Analysis
aja.sagepub.com — “Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia: An ADAS-Cog Factor Analysis” View full resource at aja.sagepub.com
Most Recently Shared on October 19, 2011 at 1:54 am By:
Dr. Bjorn Krane Physician, Doctor, and Neurologist
Rivastigmine in Alzheimer's Disease and Parkinson's Disease Dementia: An ADAS-Cog Factor Analysis: Rivastigmine ... http://t.co/9dc5n8i8
Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon capsules - FiercePharma
fiercepharma.com — “Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules Princeton, New Jersey; July 1, 2010 -- Sandoz today announced the introduction of rivastigmine... Read more...” View full resource at fiercepharma.com
Most Recently Shared on July 1, 2010 at 7:46 pm By:
Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules. http://bit.ly/aux2sj
A Review of the First Transdermal Treatment for Alzheimer--™s Disease -- The Rivastigmine Patch | Psychiatry
touchpsychiatry.com — “A Review of the First Transdermal Treatment for Alzheimer--™s Disease” View full resource at touchpsychiatry.com
Most Recently Shared on February 19, 2011 at 2:02 pm By:
Touch Psychiatry Medical Journal and Psychology
A Review of the First Transdermal Treatment for Alzheimer’s Disease – The Rivastigmine Patch http://bit.ly/fe0Ui2
A Review of the First Transdermal Treatment for Alzheimer--™s Disease -- The Rivastigmine Patch | Psychiatry
touchpsychiatry.com — “A Review of the First Transdermal Treatment for Alzheimer--™s Disease” View full resource at touchpsychiatry.com
Most Recently Shared on December 10, 2010 at 12:54 pm By:
Touch Psychiatry Medical Journal and Psychology
A Review of the First Transdermal Treatment for Alzheimer’s Disease – The Rivastigmine Patch http://bit.ly/e5bBox
Rivastigmine in the Treatment of Alzheimer--™s Disease and Parkinson--™s Disease Dementia | Psychiatry
touchpsychiatry.com — “Alzheimer--™s disease (AD) remains the most common cause of dementia, responsible for 60--70% of cases in Europe.” View full resource at touchpsychiatry.com
Most Recently Shared on February 21, 2011 at 12:45 pm By:
Touch Psychiatry Medical Journal and Psychology
Rivastigmine in the Treatment of Alzheimer’s Disease and Parkinson’s Disease Dementia http://bit.ly/dT9On6
TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: guidance (MS Word format)
guidance.nice.org.uk — “TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: guidance (MS Word format)” View full resource at guidance.nice.org.uk
Most Recently Shared on March 27, 2011 at 4:27 pm By:
Dr. Steven Z. Kussin Doctor, Internist, Gastroenterologist, and Physician
Alzheimers-effectiveness of agents p48. Summary from me.Use 'em -don't expect much of 'em. Not working or signif... http://fb.me/t4mRWqxu
NHS Easier access to Alzheimer's drugs donepezil (Aricept), galantamine (Reminyl), memantine (Ebixa) and rivastigmine (Exelon)
webmd.boots.com — “Thousands of people with Alzheimer's disease who have been denied medical treatment could soon be given access to life-changing drugs on the NHS.” View full resource at webmd.boots.com
Most Recently Shared on October 7, 2010 at 6:46 am By:
Easier access to Alzheimer’s drugs. http://goo.gl/PtC7
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Prometax (rivastigmine) - Drugs.com MedNews
drugs.com — “The European Medicines Agency has been formally notified by Novartis Europharm Ltd of its decision to withdraw its applications for an extension of the therapeu” View full resource at drugs.com
Most Recently Shared on March 16, 2012 at 2:02 pm By:
Drugs and Devices OW OW Health
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Promet... http://t.co/eDJZGt8w #drug
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Prometax (Rivastigmine) - Drugs.com MedNews
drugs.com — “From Targeted News Service (March 15, 2012) The European Union s Medicines Agency issued the following news release The European Medicines Agency has been forma” View full resource at drugs.com
Most Recently Shared on March 16, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Promet... http://t.co/LfAgJZpP #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Neurology OW
Organizing neurology resources shared by health experts, advocates, and organizations into WisdomCards.
-
MIMS Online
MIMS is the print and online prescribing database for all healthcare professionals.
Advertisement
